课题基金 / 基金详情

Sepsis Outcomes Research

Sepsis Outcomes Research
败血症结果研究
批准号:
nhmrc : 1142494
负责人:
Prof Bala Venkatesh
金额:
$18.59万
依托单位国家:
澳大利亚
项目类别:
Practitioner Fellowships
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 2022-12-31
关键词:

项目摘要

项目成果

Prof Bala Venkatesh的其他基金

相似基金

相关文献

中文摘要
翻译
败血症是澳大利亚人群住院和ICU入院的主要原因,每年有超过15700例新发病例。在澳大利亚,每年有3000多人死于败血症,这比每年的全国公路通行费和乳腺癌、前列腺癌或结直肠癌还要多。这项研究概述了类固醇和维生素D对改善脓毒症患者恢复的影响,并了解他们在脓毒症中生存能力的遗传基础。
英文摘要
Sepsis is a major cause of hospitalization and ICU admission in Australia population corresponding to more than 15700 new cases each year. Every year more than 3000 people die from sepsis in Australia which is greater than the annual national road toll and breast, prostate or colorectal cancer. The research outlined in this proposal to study the effect of steroids and vitamin D to improve patient’s recovery from sepsis and also understand the genetic basis behind their ability to survive sepsis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Management of burn injury: Fluid dynamics and antibiotic pharmacokinetics
  • 批准号:
    nhmrc : 351519
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $22.83万
  • 财政年份:
    2005
  • 负责人:
    Prof Bala Venkatesh
  • 依托单位:
STudy of Risk Assessment To reduce complications In patients Following noncardiac surgerY (STRATIFY)
  • 批准号:
    nhmrc : 351475
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $29.07万
  • 财政年份:
    2005
  • 负责人:
    Prof Bala Venkatesh
  • 依托单位:
海外基金